Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and type 2-diabetic patients using exendin [9-39] as a GLP-1 receptor antagonist.

Michael A Nauck, J Kind, Lars D Köthe, Jens Juul Holst, Carolyn F. Deacon, M Broschag, YL He, L Kjems, J. Foley

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and type 2-diabetic patients using exendin [9-39] as a GLP-1 receptor antagonist.'. Together they form a unique fingerprint.

Medicine & Life Sciences